This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Biodics, Other. Active years: 2003-2014.
Location History:
- Mainz, DE (2003 - 2006)
- Heidelberg, DE (2014)
Company Filing History:
1 out of 1 
2 out of 834,411 Years Active: 2003-2014
Title: Michael Moos: Innovator in Antibody Detection and Neutralization
Introduction
Michael Moos is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of methods for detecting and neutralizing toxins. With a total of 3 patents to his name, his work has implications for both therapeutic and diagnostic applications.
Latest Patents
One of his latest patents involves a method for detecting and identifying a variant strain in a sample. This method includes several steps: obtaining a sample of excreta or tissue from a human or animal patient, bringing the sample into contact with at least one antibody from various antibody groups, detecting the antibody reaction, constructing a reaction pattern, and comparing it with reference patterns from known strains. This innovative approach enhances the accuracy of strain identification in medical diagnostics.
Another significant patent relates to monoclonal antibodies that can recognize and neutralize epitopes from the ligand domain, translocation domain, or catalytic domain of enterotoxins and cytotoxins. This invention has therapeutic and prophylactic applications for diseases caused by these toxins, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Michael Moos has worked with various companies, including Biodics. His experience in the biotechnology sector has allowed him to develop groundbreaking technologies that address critical health challenges.
Collaborations
Michael has collaborated with notable professionals in his field, including Christoph Von Eichel-Streiber and Karina Gisch. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Michael Moos is a distinguished inventor whose work in antibody detection and neutralization has the potential to significantly impact medical diagnostics and treatment. His innovative patents reflect his dedication to improving health outcomes through scientific advancement.